Allworth Financial’s Precision BioSciences DTIL Stock Holding History

Allworth Financial’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.2K	Hold	4,769	–	–	﹤0.01%	2799
2025 Q4	$19.8K	Hold	4,769	–	–	﹤0.01%	2838
2025 Q3	$26.3K	Hold	4,769	–	–	﹤0.01%	2532
2025 Q2	$20K	Hold	4,769	–	–	﹤0.01%	2524
2025 Q1	$26.2K	Hold	4,769	–	–	﹤0.01%	1914
2024 Q4	$23.7K	Hold	4,769	–	–	﹤0.01%	1991
2024 Q3	$42.7K	Hold	4,769	–	–	﹤0.01%	1480
2024 Q2	$47.1K	Hold	4,769	–	–	﹤0.01%	1413
2024 Q1	$64.7K	Hold	4,769	–	–	﹤0.01%	1195
2023 Q4	$52.2K	Hold	4,769	–	–	﹤0.01%	1180
2023 Q3	$48.8K	Hold	4,769	–	–	﹤0.01%	1126
2023 Q2	$75.3K	Hold	4,769	–	–	﹤0.01%	990
2023 Q1	$108K	Hold	4,769	–	–	﹤0.01%	831
2022 Q4	$170K	Hold	4,769	–	–	﹤0.01%	670
2022 Q3	$186K	Hold	4,769	–	–	﹤0.01%	604
2022 Q2	$229K	Buy	+4,769	New	+$280K	﹤0.01%	534

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Allworth Financial's DTIL Position: Q1 2026 in Review

Allworth Financial held its Precision BioSciences (DTIL) position steady in Q1 2026 at 4,769 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2799.

Allworth Financial first reported a position in DTIL in Q2 2022 and has held it in 16 quarters since. The position peaked at $229K in Q2 2022. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Allworth Financial held 4,769 shares of Precision BioSciences worth $26.2K as of Q1 2026.
Allworth Financial left its Precision BioSciences share count unchanged in Q1 2026.
Precision BioSciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #2799 holding.
Allworth Financial first reported a position in Precision BioSciences in Q2 2022 and has held it in 16 quarters since.
Allworth Financial's Precision BioSciences position peaked at $229K in Q2 2022.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.